BIOMAT Database Logo BIOMAT Database Logo

Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. 1999

V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland 97201, USA.

The D4 dopamine receptor, a member of the D2-like dopamine receptor family, may be important in the etiology and treatment of schizophrenia. The present study was designed to examine the effects of dopamine agonist exposure on adenylate cyclase activity in HEK293 cells stably expressing recombinant-D4 receptors. Two hour pretreatment with dopamine receptor agonists resulted in heterologous sensitization of forskolin-stimulated cyclic AMP accumulation in intact cells expressing the D4.2, D4.4, or D4.7 dopamine receptor variant. The potency and efficacy of dopamine for sensitization of cyclic AMP accumulation was comparable at all D4 receptor variants. D4 dopamine receptor-mediated sensitization was blocked by the D4 antagonist, clozapine, and prevented by overnight pretreatment with pertussis toxin, implying a role for Gi/Go proteins in heterologous sensitization. Further, long-term (18 h) agonist exposure resulted in a greater degree of sensitization of forskolin-stimulated cyclic AMP accumulation in both intact cells and membrane preparations of cells expressing the D4 receptor, compared to 2 h agonist exposure, without altering the density of the receptors. In addition, long-term agonist exposure decreased the abundance of Gialpha without altering the abundance of Gsalpha, whereas short-term agonist treatment had no effect on the immunoreactivity of either G protein. In summary, long-term agonist-induced sensitization of adenylate cyclase by the D4 receptor may involve mechanisms that do not contribute to short-term sensitization.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000262 Adenylyl Cyclases Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP. Adenyl Cyclase,Adenylate Cyclase,3',5'-cyclic AMP Synthetase,Adenylyl Cyclase,3',5' cyclic AMP Synthetase,AMP Synthetase, 3',5'-cyclic,Cyclase, Adenyl,Cyclase, Adenylate,Cyclase, Adenylyl,Cyclases, Adenylyl,Synthetase, 3',5'-cyclic AMP
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2
D050638 Receptors, Dopamine D4 A subtype of dopamine D2 receptors that has high affinity for the antipsychotic CLOZAPINE. Dopamine D4 Receptors,Dopamine D4 Receptor,Receptor, Dopamine D4,D4 Receptor, Dopamine,D4 Receptors, Dopamine
D018491 Dopamine Agonists Drugs that bind to and activate dopamine receptors. Dopamine Receptor Agonists,Dopaminergic Agonists,Agonists, Dopamine Receptor,Agonists, Dopaminergic,Dopamine Agonist,Dopamine Receptor Agonist,Dopaminergic Agonist,Receptor Agonists, Dopamine,Agonist, Dopamine,Agonist, Dopamine Receptor,Agonist, Dopaminergic,Agonists, Dopamine,Receptor Agonist, Dopamine
D019204 GTP-Binding Proteins Regulatory proteins that act as molecular switches. They control a wide range of biological processes including: receptor signaling, intracellular signal transduction pathways, and protein synthesis. Their activity is regulated by factors that control their ability to bind to and hydrolyze GTP to GDP. EC 3.6.1.-. G-Proteins,GTP-Regulatory Proteins,Guanine Nucleotide Regulatory Proteins,G-Protein,GTP-Binding Protein,GTP-Regulatory Protein,Guanine Nucleotide Coupling Protein,G Protein,G Proteins,GTP Binding Protein,GTP Binding Proteins,GTP Regulatory Protein,GTP Regulatory Proteins,Protein, GTP-Binding,Protein, GTP-Regulatory,Proteins, GTP-Binding,Proteins, GTP-Regulatory

Related Publications

V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Sensitization of adenylate cyclase by short-term activation of 5-HT1A receptors.
December 2003, Cellular signalling,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
October 1996, Molecular pharmacology,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.
August 1997, Molecular pharmacology,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
June 2001, The Journal of pharmacology and experimental therapeutics,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Molecular mechanisms for heterologous sensitization of adenylate cyclase.
July 2002, The Journal of pharmacology and experimental therapeutics,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Dopamine-induced homologous and heterologous desensitizations of adenylate cyclase-coupled receptors on striatal neurons.
October 1990, European journal of pharmacology,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.
June 2005, Pharmacology & therapeutics,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats.
March 1995, European journal of pharmacology,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Heterologous sensitization of adenylate cyclase activity by serotonin in the rat cerebral cortex.
December 1993, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
V J Watts, and M N Vu, and B L Wiens, and V Jovanovic, and H H Van Tol, and K A Neve
Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase.
December 1992, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!